Amdocs (NASDAQ:DOX) Issues FY 2025 Earnings Guidance

Amdocs (NASDAQ:DOX) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 6.859-7.116 for the period, compared to the consensus earnings per share estimate of 6.440. The company issued revenue guidance of $4.5 billion-$4.6 billion, compared to the consensus revenue estimate of $5.0 billion. Amdocs also updated its FY25 guidance to $6.86-7.12 EPS.

Amdocs Stock Down 2.3 %

Amdocs stock opened at $85.71 on Friday. The company’s 50-day moving average price is $88.18 and its two-hundred day moving average price is $83.94. The stock has a market cap of $10.07 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.42 and a beta of 0.74. Amdocs has a 52 week low of $74.41 and a 52 week high of $94.04. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.479 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.24%. Amdocs’s payout ratio is 45.28%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on DOX. Oppenheimer lifted their price target on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday. Barclays dropped their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Finally, Stifel Nicolaus initiated coverage on shares of Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $101.83.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.